Abo Bibliothek: Guest
Critical Reviews™ in Oncogenesis

Erscheint 4 Ausgaben pro Jahr

ISSN Druckformat: 0893-9675

ISSN Online: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Methods for Detection of Subtle Mutations in Cancer Genomes

Volumen 12, Ausgabe 1-2, 2006, pp. 41-74
DOI: 10.1615/CritRevOncog.v12.i1-2.40
Get accessGet access

ABSTRAKT

With the realization that cancer is a genetic disease, detection of mutations in genomic DNA has become an important discipline in many areas of cancer research. Although the publication of the human genome sequence and the immense technological advancements have facilitated the analysis of cancer genomes, detection of mutations in tumor specimens may still be challenging and fraught with technical problems. In this review, we describe current technologies for detection of small DNA mutations, including mutation scanning techniques to search for unknown mutations, and diagnostic techniques to detect known cancer mutations. We outline the principles of the different techniques and discuss their advantages and limitations. We also discuss critical issues that must be considered before choosing methodology, including sensitivity, specificity, limit of detection, throughput and cost, quantity and quality of template DNA, available equipment, and personnel expertise.

REFERENZIERT VON
  1. Thode C., Bilde A., Von Buchwald C., Dabelsteen E., TP53 mutations in clinically normal mucosa adjacent to oral carcinomas, Journal of Oral Pathology & Medicine, 39, 9, 2010. Crossref

  2. Berge Gisle, Costea Daniela Elena, Berg Marianne, Rasmussen Heidi, Grotterød Ida, Lothe Ragnhild A., Mælandsmo Gunhild M., Flatmark Kjersti, Coexpression and nuclear colocalization of metastasis-promoting protein S100A4 and p53 without mutual regulation in colorectal carcinoma, Amino Acids, 41, 4, 2011. Crossref

  3. Serizawa Reza R., Ralfkiaer Ulrik, Steven Kenneth, Lam Gitte W., Schmiedel Sven, Schüz Joachim, Hansen Alastair B., Horn Thomas, Guldberg Per, Integrated genetic and epigenetic analysis of bladder cancer reveals an additive diagnostic value of FGFR3 mutations and hypermethylation events, International Journal of Cancer, 129, 1, 2011. Crossref

  4. Serizawa Reza, Guldberg Per, DNA Biomarkers in the Diagnosis and Management of Cancer, in Molecular Diagnostics, 2010. Crossref

Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen Preise und Aborichtlinien Begell House Kontakt Language English 中文 Русский Português German French Spain